CRO · Private company · Wilmington, NC, US
PPD Development, LP
Track this companyFree. Adds PPD Development, LP to your Dealase workspace and tells you when its record changes.
Clinical trials2516 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Cohort A: vilobelimabPhase 2 · Acute Respiratory Distress Syndrome (ARDS)ClinicalTrials.gov · fetched Nov 12, 2026
- Cohort B: paridiprubartPhase 2 · Acute Respiratory Distress Syndrome (ARDS)ClinicalTrials.gov · fetched Nov 12, 2026
- Cohort C: bevacizumabPhase 2 · Acute Respiratory Distress Syndrome (ARDS)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick ExposurePHASE2 · ACTIVE_NOT_RECRUITING · started Mar 9, 2026ClinicalTrials.gov NCT07562087 · fetched Nov 12, 2026
- Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab UsersPHASE4 · RECRUITING · started Jan 16, 2026ClinicalTrials.gov NCT06594068 · fetched Nov 12, 2026
- Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)PHASE2 · RECRUITING · started Jan 16, 2026ClinicalTrials.gov NCT07053800 · fetched Nov 12, 2026
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: BevacizumabPHASE2 · RECRUITING · started Oct 28, 2025ClinicalTrials.gov NCT06701656 · fetched Nov 12, 2026
- Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab UsersRECRUITING · started Jul 1, 2025ClinicalTrials.gov NCT06659029 · fetched Nov 12, 2026
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: VilobelimabPHASE2 · RECRUITING · started Jun 21, 2025ClinicalTrials.gov NCT06701682 · fetched Nov 12, 2026
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: ParidiprubartPHASE2 · RECRUITING · started Jun 10, 2025ClinicalTrials.gov NCT06701669 · fetched Nov 12, 2026
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)PHASE2 · RECRUITING · started Jun 10, 2025ClinicalTrials.gov NCT06703073 · fetched Nov 12, 2026
- To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant HypertensionPHASE2 · RECRUITING · started Nov 17, 2024ClinicalTrials.gov NCT06343298 · fetched Nov 12, 2026
- Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy VolunteersPHASE1 · COMPLETED · started Jul 18, 2024ClinicalTrials.gov NCT06422767 · fetched Nov 12, 2026
- A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy VolunteersPHASE1 · COMPLETED · started Jul 2, 2024ClinicalTrials.gov NCT06398730 · fetched Nov 12, 2026
- Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia VeraPHASE3 · RECRUITING · started Mar 26, 2024ClinicalTrials.gov NCT06093672 · fetched Nov 12, 2026
- Department of Defense PTSD Adaptive Platform Trial - Master ProtocolPHASE2 · SUSPENDED · started Nov 2, 2023ClinicalTrials.gov NCT05422612 · fetched Nov 12, 2026
- Department of Defense PTSD Adaptive Platform Trial - Intervention C - DaridorexantPHASE2 · SUSPENDED · started Nov 2, 2023ClinicalTrials.gov NCT05948540 · fetched Nov 12, 2026
- A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their OffspringRECRUITING · started Jul 25, 2023ClinicalTrials.gov NCT05721937 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral TherapyPHASE3 · COMPLETED · started Jul 6, 2023ClinicalTrials.gov NCT05917509 · fetched Nov 12, 2026
- A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Dec 13, 2022ClinicalTrials.gov NCT05602025 · fetched Nov 12, 2026
- Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate BindersPHASE4 · COMPLETED · started Jun 8, 2022ClinicalTrials.gov NCT04485039 · fetched Nov 12, 2026
- A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)PHASE3 · ACTIVE_NOT_RECRUITING · started May 19, 2022ClinicalTrials.gov NCT05123703 · fetched Nov 12, 2026
- A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILDPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 1, 2021ClinicalTrials.gov NCT04691154 · fetched Nov 12, 2026
- Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved IndicationsRECRUITING · started Jul 30, 2021ClinicalTrials.gov NCT04846959 · fetched Nov 12, 2026
- TH1902 in Patients With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 4, 2021ClinicalTrials.gov NCT04706962 · fetched Nov 12, 2026
- Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2PHASE3 · ACTIVE_NOT_RECRUITING · started Feb 8, 2021ClinicalTrials.gov NCT04229979 · fetched Nov 12, 2026
- Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil LevelPHASE3 · COMPLETED · started Oct 30, 2019ClinicalTrials.gov NCT04133909 · fetched Nov 12, 2026
- Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KGPHASE4 · COMPLETED · started Jul 19, 2019ClinicalTrials.gov NCT04392739 · fetched Nov 12, 2026
NIH awards10
- TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CTFiscal year 2026 · $2MNIH RePORTER 271201600005I-0-759802600001-1 · fetched Nov 12, 2026
- PPDs Application for the Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed)Fiscal year 2026 · $9MNIH RePORTER 5U01AI178756-04 · fetched Nov 12, 2026
- Clinical Trial Site Monitoring for Phase III Study: A5300B/I2003B (PHOENIx)Fiscal year 2026 · $3.1MNIH RePORTER 75N93021D00035-0-759302600001-1 · fetched Nov 12, 2026
- HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)Fiscal year 2026 · $8.9MNIH RePORTER 75N93021D00035-P00002-759302400002-1 · fetched Nov 12, 2026
- NIAID Division of AIDS (DAIDS) Clinical Site MonitoringFiscal year 2026 · $25.2MNIH RePORTER 75N93021D00035-P00004-759302400001-1 · fetched Nov 12, 2026
- REGULATORY MANAGEMENT CENTER (RMC)Fiscal year 2026 · $2.9MNIH RePORTER 75N93022C00001-P00018-9999-3 · fetched Nov 12, 2026
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)Fiscal year 2026 · $7.8MNIH RePORTER 75N93022C00014-P00005-9999-1 · fetched Nov 12, 2026
- Task A: Early Phase Clinical Trial Units (EPCTU)Fiscal year 2026 · $183.5KNIH RePORTER 75N93022D00017-P00004-759302200001-1 · fetched Nov 12, 2026
- VACCINE MANUFACTURING SERVICES FOR INFECTIOUS DISEASESFiscal year 2026 · $10KNIH RePORTER 75N98026D00092-0-9999-1 · fetched Nov 12, 2026
- Clinical Trial Site Monitoring for PHOENIx MDR-TBFiscal year 2025 · $985KNIH RePORTER 272201700002I-P00009-759301900131-1 · fetched Nov 12, 2026